Pregnant women's use of e-cigarettes in the UK: a cross-sectional survey.
Adult
Attitude to Health
Cigarette Smoking
/ epidemiology
Cross-Sectional Studies
Culture
Educational Status
England
/ epidemiology
Female
Health Knowledge, Attitudes, Practice
Humans
Intention
Motivation
Pregnancy
Pregnant Women
/ psychology
Scotland
/ epidemiology
Smoking Cessation
/ psychology
Vaping
/ epidemiology
E-cigarettes
pregnancy
prevalence
smoking
vaping
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
accepted:
24
09
2020
pubmed:
5
10
2020
medline:
18
5
2021
entrez:
4
10
2020
Statut:
ppublish
Résumé
To estimate prevalence of vaping in pregnancy. Compare characteristics and attitudes between exclusive smokers and vapers, and between exclusive vapers and dual users (smoke and vape). Cross-sectional survey. Hospitals across England and Scotland. Pregnant women attending antenatal clinics in 2017. Women at 8-24 weeks' gestation completed screening questions about their smoking and vaping. Current or recent ex-smokers and/or vapers completed a full detailed survey about vaping and smoking. The prevalence of vaping, characteristics and attitudes of women who vape and/or smoke. Of 3360 pregnant women who completed screening questions, 515 (15.3%, 95% CI 14.1-16.6) were exclusive smokers, 44 (1.3%, 95% CI 1.0-1.8) exclusive vapers and 118 (3.5%, 95% CI 2.9-4.2) dual users. In total, 867 (25.8%) women completed the full survey; compared with smokers (n = 434), vapers (n = 140) were more likely to hold higher educational qualifications (odds ratio [OR) 1.51, 95% CI 1.01-2.25). Compared with exclusive vapers (n = 33), dual users (n = 107) were younger (OR 0.91 95% CI 0.85-0.98) and less likely to hold high qualifications (OR 0.43, 95% CI 0.20-0.96). Compared with smokers, dual users were more likely to be planning to quit smoking (OR 2.27, 95% CI 1.24-4.18). Compared with smokers, vapers were more likely to think vaping was safer than smoking (78.6% versus 36.4%). One in 20 pregnant women report vaping, and most also smoke. Dual users are more motivated towards stopping smoking than smokers. Where women have tried but cannot stop smoking, clinicians could encourage them to consider vaping for smoking cessation. One in 20 women report vaping during pregnancy but of those that do vape, most also smoke, despite having intentions to quit.
Identifiants
pubmed: 33012050
doi: 10.1111/1471-0528.16553
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
984-993Subventions
Organisme : Cancer Research UK, Tobacco Advisory Group Project
ID : C53479/A22733
Informations de copyright
© 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Références
Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. NEnglJMed 2008;359:61-73.
Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004;6(S2):S125-S140.
Delpisheh A, Kelly Y, Rizwan S, Attia E, Drammond S, Brabin BJ. Population attributable risk for adverse pregnancy outcomes related to smoking in adolescents and adults. Public Health 2007;121:861-8.
Clifford A, Lang L, Chen R. Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: A literature review. Neurotoxicol Teratol 2012;34:560-70.
Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health 2018;6:e769-e776.
McAndrew F, Thompson J, Fellows L, Large A, Speed M, Renfrew MJ. Infant Feeding Survey 2010: Health and Social Care Information Centre. 2012.
Health & Social Care Information Centre. Statistics on Smoking. England. 2018.
Hajek P, Stead Lindsay F, West R, Jarvis M, Hartmann-Boyce J, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2013;2:CD003999.
McBride CM, Pirie PL, Curry SJ. Postpartum relapse to smoking: a prospective study. Health Educ Res 1992;7:381-90.
Fingerhut LA, Kleinman JC, Kendrick JS. Smoking before, during, and after pregnancy. Am J Public Health 1990;80:541-4.
McNeill A, Brose L, Calder R, Bauld L, Robson D. Vaping in England: an evidence update including mental health and pregnancy, March 2020: a report commissioned by Public Health England. London: Public Health England; 2020.
Gravely S, Fong GT, Cummings KM, Yan M, Quah ACK, Borland R, et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: findings from the ITC project. Int J Environ Res Public Health 2014;11:11691.
Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control 2016;26:96-104.
Mirbolouk M, Charkhchi P, Kianoush S, Uddin SMI, Orimoloye OA, Jaber R, et al. Prevalence and distribution of e-cigarette use among U.S. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med 2018;169:429-38.
West R, Brown J, Beard E.Smoking Toolkit study: Trends in electronic cigarette use in England- latest trends: Smoking in England; 2019 [available at: http://www.smokinginengland.info/].
Action on Smoking and Health (ASH). Use of e-cigarettes (vaporisers) among adults in Great Britain 2019 [available at: https://ash.org.uk/wp-content/uploads/2019/09/Use-of-e-cigarettes-among-adults-2019.pdf].
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. NEnglJMed 2019;0:null.
Britton J, Arnott D, McNeill A, Hopkinson N. Nicotine without smoke-putting electronic cigarettes in context. BMJ 2016;353:1-3.
Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis U, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: A cross-sectional study. Ann Intern Med 2017;166:390-400.
Kapaya M, D’Angelo DV, Tong VT, England L, Ruffo N, Cox S, et al. Use of electronic vapor products before, during, and after pregnancy among women with a recent live birth - Oklahoma and Texas, 2015. MMWR Morb Mortal Wkly Rep 2019;68:189-94.
Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M. Knowledge, attitudes, and practice of electronic cigarette use among pregnant women. J Addict Med 2015;9:266-72.
Liu B, Xu G, Rong S, Santillan DA, Santillan MK, Snetselaar LG, et al. National Estimates of e-Cigarette Use Among Pregnant and Nonpregnant Women of Reproductive Age in the United States, 2014-2017e-Cigarette Use Among US Women of Reproductive Age, 2014-2017Letters. 2019. DOI: 10.1001/jamapediatrics.2019.0658.
Whittington JR, Simmons PM, Phillips AM, Gammill SK, Cen R, Magann EF, et al. The use of electronic cigarettes in pregnancy: a review of the literature. Obstet Gynecol Surv 2018;73:544-9.
Cooper S, Orton S, Campbell K, Ussher M, Coleman-Haynes N, Whitemore R, et al. Attitudes to E-cigarettes and cessation support for pregnant women from english stop smoking services: a mixed methods study. Int J Environ Res Public Health 2019;16:110.
Wickström R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol 2007;5:213-22.
Cardenas VM, Cen R, Clemens MM, Moody HL, Ekanem US, Policherla A, et al. Use of electronic nicotine delivery systems (ENDS) by pregnant women I: Risk of small-for-gestational-age birth. Tob Induc Dis 2019;17:44.
Gillen S, Saltzman D. Antenatal exposure to e-cigarette vapor as a possible etiology to total colonic necrotizing enterocolitits: A case report. J Pediatr Surg Case Rep 2014;2:536-7.
Clemens MM, Cardenas VM, Fischbach LA, Cen R, Siegel ER, Eswaran H, et al. Use of electronic nicotine delivery systems by pregnant women II: Hair biomarkers for exposures to nicotine and tobacco-specific nitrosamines. Tob Induc Dis 2019;17:50.
McDonnell B, Dicker P, Regan C. Electronic cigarettes and obstetric outcomes: a prospective observational study. BJOG 2020;127:750-6.
Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect 2000;108:1159-64.
Burtles S.Pregnancy Trial of E-cigarettes and Patches (PREP): NHS Health Research Authority 2017 [available at: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/pregnancy-trial-of-e-cigarettes-and-patches-prep/].
Smoking in Pregnancy Challenge Group. Use of electronic cigarettes before, during and after pregnancy. A guide for maternity and other healthcare professionals; 2019.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.
Des Jarlais DC, Lyles C, Crepaz N, Group T. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94:361-6.
Cooper S, Bowker K, Lewis S, Ussher M, Coleman T, Orton S, et al. Attitudes to and use of electronic cigarettes: a multi-centre longitudinal cohort survey of smokers, recent ex-smokers and vapers during pregnancy and postpartum. (Pregnancy Lifestyle Survey 2017) https://osf.io/3cxen/: OSF; 2019 [Study protocol].
Research Registry. Attitudes to and use of electronic cigarettes: a multi-centre longitudinal cohort survey of smokers, recent ex-smokers and vapers during pregnancy and postpartum. Reference 4917 Research registry 2019 [available at: https://www.researchregistry.com].
Bowker K, Orton S, Cooper S, Naughton F, Whitemore R, Lewis S, et al. Views on and experiences of electronic cigarettes: a qualitative study of women who are pregnant or have recently given birth. BMC Pregnancy Child 2018;18:233.
Pearson JL, Hitchman SC, Brose LS, Bauld L, Glasser AM, Villanti AC, et al. Recommended core items to assess e-cigarette use in population-based surveys. Tob Control 2017.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989;84:791-9.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-27.
Husten CG. How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res 2009;11:111-21.
Orton S, Bowker K, Cooper S, Naughton F, Ussher M, Pickett KE, et al. Longitudinal cohort survey of women's smoking behaviour and attitudes in pregnancy: study methods and baseline data. BMJ Open 2014;4:e004915.
Pickett KE, Wood C, Adamson J, DeSouza L, Wakschlag LS. Meaningful differences in maternal smoking behaviour during pregnancy: implications for infant behavioural vulnerability. J Epidemiol Community Health 2008;62:318-24.
National institute for Health Research. Clinical Research Network NIHR; 2020 [available at: https://www.nihr.ac.uk/explore-nihr/support/clinical-research-network.htm].
Dex S, Joshi H. Millennium Cohort Study First Survey: a user’s guide to initial findings: Centre for Longitudinal Studies, Institute of Education, University of London; 2004.
McHugh A. Implementing the fetal anomaly scan coverage KPI: a progress report. Public Health Engl 2018. https://phescreening.blog.gov.uk/2018/05/14/implementing-the-fetal-anomaly-scan-coverage-kpi-aprogress-report/.
Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ 2009;339:b4347.
Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data. J R Coll Gen Pract 2014;64:e554-e560.
Kurti AN, Redner R, Lopez AA, Keith DR, Villanti AC, Stanton CA, et al. Tobacco and nicotine delivery product use in a national sample of pregnant women. Prev Med 2017;104:50-6.
Robertson L, Hoek J, Blank ML, Richards R, Ling P, Popova L. Dual use of electronic nicotine delivery systems (ENDS) and smoked tobacco: a qualitative analysis. Tob Control 2019;28:13-9.
McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila) 2015;8:873-8.
Ginzel KH, Maritz GS, Marks DF, Neuberger M, Pauly JR, Polito JR, et al. Critical review: nicotine for the fetus, the infant and the adolescent?. [Review] [78 refs]. J Health Psychol 2007;12:215-24.
Ogburn PL Jr, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999;181:736-43.
Wright LN, Thorp JM Jr, Kuller JA, Shrewsbury RP, Ananth C, Hartmann K. Transdermal nicotine replacement in pregnancy: Maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol 1997;176:1090-4.
Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015:1-59.
Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respir Med 2014;2:728-37.